drug
FAVLYXA
updated 6mo agoby Avyxa Pharma LLC
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval134 co-mentions · 66 sources
- drugEfudex73 co-mentions · 72 sources
- drugFLUOROURACIL73 co-mentions · 72 sources
- companyFresenius Kabi USA LLC12 co-mentions · 12 sources
- drugRNS-6012 co-mentions · 12 sources
- tagOncology5 co-mentions · 2 sources
- drugOXALIPLATIN1 co-mentions · 1 sources
- drugEntia1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying FAVLYXA
- phase2A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- phase2Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
- phase2A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
- phase3A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- phase1A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- phase2Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma
- phase2Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
- phase2Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
News(1)
- Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic CancerDeirdre J. Cohen, MD, MS, discusses clinical decision-making and the comparative efficacy of FOLFIRINOX and NALIRIFOX in metastatic pancreatic cancer.onclive · 6mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that